Quintus Ngumah, OD, PhD
PTC Therapeutics · Bausch & Lomb Incorporated
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Quintus Ngumah, OD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:11 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT04439071 · A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)PTC Therapeutics · terminated · Pneumonia, COVID-19, Coronavirus · study director
- Ph2NCT02647359 · Study of Ataluren in Participants With Nonsense Mutation AniridiaPTC Therapeutics · completed · Aniridia · study director
- Ph1NCT01895985 · Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male VolunteersBausch & Lomb Incorporated · completed · Intraocular Pressure · study director
- Ph1NCT01736462 · Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 DaysBausch & Lomb Incorporated · completed · Corneal Endothelial Cell Changes · study director
- Ph2NCT01707381 · BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionBausch & Lomb Incorporated · completed · Ocular Hypertension, Open Angle Glaucoma · study director
- Ph3NCT01591655 · Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryBausch & Lomb Incorporated · completed · Cataract, Inflammation, Surgery · study director
- Ph3NCT01591161 · Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryBausch & Lomb Incorporated · completed · Cataract, Inflammation, Surgery · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.